Clinical Trial Update: Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer [Phase 1]

View source ↗

Summary

This document reports the completion and posting of results for a Phase 1 safety study of capecitabine with radiation in elderly patients with rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Rectal Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2015-04-20